Smith & Nephew picks up Tusker Medical and its in-office ear tube treatment

baby ear hearing
Smith & Nephew described the system as complementary to its ear, nose and throat business, which includes tonsillectomy and soft tissue products. (Pixabay)

Just weeks after it received FDA approval for its in-office system for placing eardrum tubes and treating ear infections, Tusker Medical has been picked up by Smith & Nephew for an undisclosed sum.

The devicemaker described the acquisition as part of its strategy to invest in technologies that address unmet clinical needs. Tusker’s Tula system, previously granted an FDA breakthrough device designation, is aimed at the 700,000 children who undergo surgery annually for recurrent ear infections or persistent fluid in the middle ear.

Typically, tympanostomy tubes are placed within the ear under general anesthesia in an operating room. The automated Tula device, meanwhile, is designed to be used within a physician’s office, with a local anesthetic, as the child sits up.

FREE DAILY NEWSLETTER

Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

RELATED: Smith & Nephew CEO Nawana to exit over salary; Ex-Roche Dx chief Diggelmann to step in

Smith & Nephew described the system as complementary to its ear, nose and throat business, which includes tonsillectomy and soft tissue products used by general and pediatric ENT surgeons.

“The Tula System is a truly innovative option for physicians treating incredibly common ear conditions,” Smith & Nephew’s president of sports medicine and ENT, Brad Cannon, said in a statement. “It is a game-changer when treating children, removing the risk and stress of general anesthesia for patients and caregivers.”

All of Tusker’s employees are expected to join the company, with Smith & Nephew planning a commercial launch of the Tula system in the U.S. in the first quarter of this year.

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Loretta Itri, M.D. has been helping Immunomedics out with its troubled antibody-drug conjugate. Now, she’s signing on as its chief medical officer.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.